Lyvispah
Product Images NDC 70257-412
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lyvispah (NDC 70257-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Saol Therapeutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Packet-image (Lyvispah 02)
5mg Carton (Lyvispah 03)
5mg Container (Lyvispah 04)
10mg Carton (Lyvispah 05)
10mg Container (Lyvispah 06)
20mg Carton (Lyvispah 07)
20mg Container (Lyvispah 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.